Mark E Nance's Net Worth
$1.45 Million
Who is Mark E Nance?
Mark E Nance has an estimated net worth of $1.45 Million. This is based on reported shares across multiple companies, which include Envista Holdings Corp, and Insys Therapeutics, Inc..
SEC CIK
Mark E Nance's CIK is 0001755882
Past Insider Trading and Trends
2021 was Mark E Nance's most active year for acquiring shares with 9 total transactions. Mark E Nance's most active month to acquire stocks was the month of January. 2021 was Mark E Nance's most active year for disposing of shares, totalling 25 transactions. Mark E Nance's most active month to dispose stocks was the month of August. 2021 saw Mark E Nance paying a total of $575,314.68 for 64,975 shares, this is the most they've acquired in one year. In 2021 Mark E Nance cashed out on 41,625 shares for a total of $939,215.69, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Envista Holdings Corp (NVST) Snapshot price: $24.52
General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +48.49% | 18.93K |
$22.65 | -$58,890.00 | 57.97K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +14.69% | 5K |
$21.75 | $108,750.00 | 39.04K |
Nov 8
| |||
Form 4
| -1.42% | -492.00 |
$35.07 | -$17,254.44 | 34.04K |
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
| +13.80% | 4.19K |
$38.25 | -$77,303.25 | 34.53K |
Feb 25
| |||
Form 4
| -1.75% | -540.00 |
$38.79 | -$20,946.60 | 30.34K |
Jul 15
| |||
Form 4
| +10.77% | 3K |
$48.52 | -$79,427.24 | 30.89K |
Feb 25
| |||
Form 4
|
—
|
0
|
$35.53 | -$73,266.79 | 27.88K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$35.52 | -$16,603.20 | 27.88K |
Scheduled
|
Sep 2
| ||
Form 4
|
—
|
0
|
$35.56 | -$10,281.84 | 27.88K |
Scheduled
|
Aug 2 - Aug 3
| ||
Form 4
| -1.90% | -540.00 |
$41.91 | -$22,631.40 | 27.88K |
Jul 15
| |||
Form 4
|
—
|
0
|
$35.39 | -$247,067.90 | 28.42K |
Scheduled
|
Jun 11
| ||
Form 4
| +42.53% | 8.48K |
$37.94 | -$28,417.06 | 28.42K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| -2.64% | -540.00 |
$21.85 | -$11,799.00 | 19.94K |
Jul 15
| |||
Form 4
| +123.69% | 11.32K |
—
|
—
| 20.48K |
Feb 25
| |||
Form 4
|
∞
| 9.16K |
—
|
—
| 9.16K |
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Insys Therapeutics, Inc. No price found
Chief Legal Officer & Gen Cnsl
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +66.67% | 10K |
—
|
—
| 25K |
Jan 25
| |||
Form 4
| +66.67% | 10K |
—
|
—
| 25K |
Jan 25
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||